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Extraosseous Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) is an uncommon, aggressive, and 
malignant tumor with a poor patient outcome. Its occurrence in the lesser sac is a rare event and to the best of our 
knowledge, has not been previously described. The present case was clinically and radiologically misdiagnosed as a 
pancreatic tumor/gastrointestinal stromal tumor. Histopathology revealed a tumor with “small round cells” that were positive 
for CD99, confirming the diagnosis of ES/PNET. This report highlights the importance of considering Ewing’s sarcoma in 
the differential diagnosis of intraabdominal, extraintestinal masses. 
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INTRODUCTION
Ewing’s sarcoma (ES) was first described as an osteolyt-
ic bone tumor composed of malignant, small round cells 
by James Ewing in 1921. Extraosseous Ewing’s sarcoma 
was first described by Tefft in 1969 [1]; it is a rare, ma-
lignant mesenchymal tumor similar to intraosseous ES. 
Since its characterization in 1980s, this tumor has increas-
ingly been reported from diverse sites including the oral 
cavity, salivary glands, subcutis, lung, heart, pericardium, 
biliary tract, kidney, urinary bladder, uterine corpus and 
cervix, gonads [2], pancreas, vagina, rectovaginal septum, 
prostate, esophagus, and stomach [3]. To the best of our 
knowledge, no reports of its occurrence in the lesser sac 
have been documented in the literature. 
CASE REPORT
A 47-year-old woman presented with a short history of 
abdominal pain of 15 days duration. There was no history 
of vomiting, diarrhea, or weight loss. Physical examination 
revealed an epigastric mass measuring 7 × 8 cm, which 
was firm in consistency and moving with respiration. No 
organomegaly was noted. Hemoglobin was 11 g/dL. All 
other laboratory parameters were within normal limits. 
Upper gastrointestinal endoscopy showed external 
indentation of the stomach. Computed tomography (CT) 
examination suggested a large, well-defined, heterog-
enously enhancing mass measuring 12 × 15 cm with an 
epicenter in the lesser sac and loss of fat planes with the 
body and part of the tail of the pancreas and posterior wall 
of stomach. Hypodense non-enhancing areas suggestive of 
necrosis or cystic change were observed. The possibility of 
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an exophytic pancreatic mass or exophytic gastrointestinal 
stromal tumor (GIST) from the posterolateral wall of the 
stomach was proposed (Fig. 1). 
The patient underwent an exploratory laparotomy, 
which showed a tumor in the lesser sac abutting the left 
dome of the diaphragm dorsally, the splenic hilum to the 
left, the transverse mesocolon inferiorly, and the posterior 
wall of stomach anteriorly. The tumor extended posterior 
to the stomach and was firmly adherent to the pancreatic 
tissue. Excision of the tumor with a distal pancreatectomy 
and splenectomy was performed and the specimen was 
received in our laboratory for histopathological examina-
tion and diagnosis. A malignant pancreatic tumor was 
suspected clinically. No additional information, such as 
serum tumor markers, was available. 
Grossly, the tumor was well-circumscribed, partly en-
capsulated, measured 10 × 15 cm, and weighed 830 g. The 
tail of the pancreas was compressed by the tumor and was 
identified near the splenic hilum. Cut section of the mass 
showed a grey tan hemorrhagic tumor with large areas of 
necrosis (corresponded to the cystic changes seen on CT) 
(Fig. 2). 
Microscopy revealed a fairly well-circumscribed tu-
mor with a fibrous pseudocapsule composed of sheets of 
small round cells with enlarged round to oval nuclei, fine 
stippled chromatin, and moderately clear to amphophilic 
cytoplasm, which was periodic acid-Schiff stain positive. 
Geographic areas of necrosis with focal peritheliomatous 
proliferation of tumor cells around the blood vessels, in-
creased mitosis, prominent apoptosis, and nuclear mould-
ing were noted. In some areas, tumor islands were sur-
rounded by desmoplastic stroma. Peripherally compressed 
pancreatic tissue was seen and no tumor infiltration was 
discerned (Figs. 3 and 4). The tumor cells were CD99 posi-
tive, while cytokeratin (CK), desmin, synaptophysin (SYP), 
and chromogranin (CHR) were negative (Fig. 5). Based 
on morphology and immunohistochemistry findings, a 
final diagnosis of extraosseous Ewing’s sarcoma/primitive 
neuroectodermal tumor (ES/PNET) of the lesser sac was 
made.
Metastatic workup of the patient was negative. She was 
scheduled for alternating IE (ifosfamide and etoposide) 
and VAC (vincristine, adriamycin, and cyclophosphamide) 
chemotherapy. Currently, the patient has completed two 
cycles of chemotherapy with no further complaints and is 
receiving regular follow-up care.
Figure 1. Computed tomography image showing a large, 
heterogenously enhancing mass with an epicenter in the lesser 
sac and loss of fat planes with the stomach and pancreas.
Figure 3. Section shows tumor nests separated from the 
pancreas (left hand corner) by broad fibrous bands (H&E, × 100).
Figure 2. Cut section of the gross specimen showing a grey tan 
mass with necrosis. Spleen (×) and compressed pancreatic tissue 
(*) are marked.
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DISCUSSION
ES and PNET are characterized by the same cytogenetic 
alterations (t(11;22) (q24;Q12) which forms EWSR1-FLI1 
fusion product) [4] and comparable morphologic and im-
munophenotypic features. They are hence classified under 
the same group of lesions – the ES/PNET family of tumors 
[5]. In their extensive review on ectopic tumors, Wick and 
Nappi [2] attributed the origin of these tumors to ectopic 
neural and neuroectodermal proliferations. They further 
suggested that although neural tissues are ubiquitously 
distributed throughout the body, the occurrence of tumors 
related to this lineage is extremely uncommon in some 
topographic sites.
ES/PNET is a poorly differentiated tumor that is inte-
grated in the morphologic category of ‘small round cell’ 
tumors [6]. The various entities that have ‘small round 
cell’ morphology occurring at this site are lymphoma, 
pancreatic endocrine tumor (PET), pancreatoblastoma, 
extra-renal Wilm’s tumor, extra-adrenal neuroblastoma, 
hepatoblastoma, rhabdomyosarcoma, desmoplastic small 
round cell tumor (DSRCT), and visceral small cell neuro-
endocrine carcinoma (SCNC). Extraosseous ES/PNET is 
rare and poses a diagnostic challenge to the pathologist. 
Specifically, there is a broad spectrum of tumors having a 
similar morphology that includes sheets of small, round 
blue cells. This problem is markedly enhanced when the 
tumor site of origin is uncertain, as observed in the pres-
ent case.
Differential diagnoses of DSRCT, SCNC, PET, and pan-
creatoblastoma were entertained based on histomorphol-
ogy in this case. DSRCT’s are usually multicentric tumors 
involving the peritoneal cavity, although extraperitoneal 
neoplasms have been described [6]. The cellular phase 
does not have much desmoplasia and can resemble soft 
tissue ES. Since the tumor cells were negative for CK and 
desmin, DSRCT was ruled out. Cell to cell molding was 
noted in the present case, which is usually seen in SCNC. 
Since the cells were negative for SYP and CHR, small cell 
neuroendocrine carcinoma and malignant PET were ruled 
out. Pancreatoblastomas are rare in adults and micro-
scopically show islands of squamoid morules amongst the 
neoplastic cells [7], which was not observed in this case. 
Strong membrane positivity for CD99 was observed in all 
of the cells confirming the diagnosis of extraosseous ES/
PNET.
Unlike intraosseous ES, the radiologic findings of ex-
traosseous lesions are non-specific. In the present case, 
the tumor was mistaken for a pancreatic tumor or GIST 
with necrosis. This confusion may be partly due to the 
unanticipated occurrence of the tumor in a previously un-
described site. 
In conclusion, extraosseus ES/PNETs are malignant, 
highly aggressive tumors, with a poor patient outcome. 
This report describes the first case of ES arising in the 
lesser sac. Even though it is rare, this entity should be 
considered in the differential diagnosis of intraabdominal, 
extraintestinal masses. A timely and accurate diagnosis 
Figure 4. Section shows sheets of small round tumor cells with 
a rim of clear cytoplasm (H&E, × 400).
Figure 5. Immunohistochemistry images. (A) Tumor cells show 
diffuse membrane positivity for CD99 (CD99, × 200). (B) Tumor 
cells are cytokeratin (CK) negative (CK, × 200). (C) Tumor cells 
are negative for Desmin (Desmin, × 200). (D) synaptophysin 
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can be obtained based on histomorphology combined with 
immunohistochemistry.
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